Evidence map›Paper›PMID 41783066›Full record

ReviewFrontiers in medicine2026

Familial interstitial lung disease: emerging insights into screening and genetic risk.

Ana Paola Hernández Cristancho, Lurdes Planas-Cerezales, Maria Molina-Molina, Raphael Borie, Wim A Wuyts, Meritxell Jodar, Jacobo Sellares, Fernanda Hernandez-Gonzalez

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana Paola Hernández CristanchoDepartment of Respiratory Medicine, Respiratory Institute, Hospital Clinic, Barcelona, Spain.
Lurdes Planas-CerezalesDepartment of Respiratory Medicine, Respiratory Institute, Hospital Clinic, Barcelona, Spain.
Maria Molina-MolinaILD Unit, Department of Respiratory, Biomedical Research Institute of Bellvitge (IDIBELL), University Hospital of Bellvitge, Barcelona, Spain.
Raphael BorieUniversité Paris Cité, UMR Inserm, CRI, Paris, France.
Wim A WuytsUnit for Interstitial Lung Diseases, Department of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium.
Meritxell JodarUniversity of Barcelona, Barcelona, Spain.
Jacobo SellaresDepartment of Respiratory Medicine, Respiratory Institute, Hospital Clinic, Barcelona, Spain.
Fernanda Hernandez-GonzalezDepartment of Respiratory Medicine, Respiratory Institute, Hospital Clinic, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Familial pulmonary fibrosis (FPF) is increasingly recognized as a distinct entity within the spectrum of interstitial lung diseases (ILDs), characterized by a significant genetic contribution involving genetic variation telomere-related genes, surfactant protein genes, and the

Indexed as

familial pulmonary fibrosisgenetic screeningidiopathic pulmonary fibrosisinterstitial lung abnormalitiesinterstitial lung disease

Identifiers

PMID41783066
PMCPMC12953370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.